Palivizumab prophylaxis in haemodynamically significant congenital heart disease.
Feltes
T F
TF
Simoes
E
E
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D003627:Data Interpretation, Statistical; D006330:Heart Defects, Congenital / Q000150:complications*; D006760:Hospitalization; D006801:Humans; D007223:Infant; D000069455:Palivizumab; D014777:Virus Diseases / Q000517:prevention & control*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab